150 related articles for article (PubMed ID: 26050796)
41. Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.
Liao Z; Feng S; Ling P; Zhang G
J Thromb Thrombolysis; 2015 Feb; 39(2):228-34. PubMed ID: 24962733
[TBL] [Abstract][Full Text] [Related]
43. Genome-wide association study of warfarin maintenance dose in a Brazilian sample.
Parra EJ; Botton MR; Perini JA; Krithika S; Bourgeois S; Johnson TA; Tsunoda T; Pirmohamed M; Wadelius M; Limdi NA; Cavallari LH; Burmester JK; Rettie AE; Klein TE; Johnson JA; Hutz MH; Suarez-Kurtz G
Pharmacogenomics; 2015; 16(11):1253-63. PubMed ID: 26265036
[TBL] [Abstract][Full Text] [Related]
44. The value of pharmacogenetic testing.
Pocinki AG
JAMA Intern Med; 2015 Feb; 175(2):314. PubMed ID: 25642672
[No Abstract] [Full Text] [Related]
45. The value of pharmacogenetic testing—reply.
Kazi DS; Hlatky MA
JAMA Intern Med; 2015 Feb; 175(2):314-5. PubMed ID: 25642673
[No Abstract] [Full Text] [Related]
46. Pharmacogenetics of Warfarin Therapy.
Ruff CT
Clin Chem; 2018 Nov; 64(11):1558-1559. PubMed ID: 29941467
[No Abstract] [Full Text] [Related]
47. Methods for Predicting Warfarin Dose Requirements.
Saffian SM; Wright DF; Roberts RL; Duffull SB
Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C Carriers.
Yang M; Choi R; Kim JS; On YK; Bang OY; Cho HJ; Lee SY
Clin Ther; 2016 Dec; 38(12):2666-2674.e1. PubMed ID: 27887741
[TBL] [Abstract][Full Text] [Related]
49. Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.
Kubo K; Ohara M; Tachikawa M; Cavallari LH; Lee MTM; Wen MS; Scordo MG; Nutescu EA; Perera MA; Miyajima A; Kaneko N; Pengo V; Padrini R; Chen YT; Takahashi H
Pharmacogenomics J; 2017 Dec; 17(6):494-500. PubMed ID: 27503578
[TBL] [Abstract][Full Text] [Related]
50. Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.
Saffian SM; Duffull SB; Roberts RL; Tait RC; Black L; Lund KA; Thomson AH; Wright DF
Ther Drug Monit; 2016 Dec; 38(6):677-683. PubMed ID: 27855133
[TBL] [Abstract][Full Text] [Related]
51. Clinical Model for Predicting Warfarin Sensitivity.
Ma Z; Cheng G; Wang P; Khalighi B; Khalighi K
Sci Rep; 2019 Sep; 9(1):12856. PubMed ID: 31492893
[TBL] [Abstract][Full Text] [Related]
52. Warfarin, genes, and the (health care) environment.
Kazi DS; Hlatky MA
JAMA Intern Med; 2014 Aug; 174(8):1338-9. PubMed ID: 24934523
[No Abstract] [Full Text] [Related]
53. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes: comment.
Gaikwad T; Ghosh K; Shetty S
J Thromb Haemost; 2017 Aug; 15(8):1708. PubMed ID: 28608988
[No Abstract] [Full Text] [Related]
54. Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans.
Alzubiedi S; Saleh MI
J Cardiovasc Pharmacol; 2016 Jan; 67(1):86-92. PubMed ID: 26355760
[TBL] [Abstract][Full Text] [Related]
55. DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction.
Tao Y; Zhang Y; Jiang B
BMC Med Genomics; 2020 Oct; 13(Suppl 10):152. PubMed ID: 33087117
[TBL] [Abstract][Full Text] [Related]
56. Genotype-guided warfarin therapy: current status.
Tavares LC; Marcatto LR; Santos PCJL
Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
[TBL] [Abstract][Full Text] [Related]
57. Developing Chinese race-specific warfarin dose prediction algorithms.
Gao W; Zhang Z; Guan Z; Chen W; Li Z
Int J Clin Pharm; 2023 Jun; 45(3):731-738. PubMed ID: 36991222
[TBL] [Abstract][Full Text] [Related]
58. Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population.
Suarez-Kurtz G; Struchiner CJ
Pharmacogenet Genomics; 2017 May; 27(5):210-211. PubMed ID: 28263279
[No Abstract] [Full Text] [Related]
59. Warfarin dosing algorithms: A systematic review.
Asiimwe IG; Zhang EJ; Osanlou R; Jorgensen AL; Pirmohamed M
Br J Clin Pharmacol; 2021 Apr; 87(4):1717-1729. PubMed ID: 33080066
[TBL] [Abstract][Full Text] [Related]
60. [Pharmacogenomics of vitamin K antagonists].
Guzmán N; Vega M; Reyes F; Guzmán-Oyarzo D; Andaur M; Boguen R; Letelier P
Rev Med Chil; 2020 Sep; 148(9):1307-1314. PubMed ID: 33399707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
